We found that CSE promoted Mstn expression by enhancing p-Erk1/2, and Mstn further inhibited Fndc5 expression by the p-Smad3/PGC-1α pathway, which may serve as a mechanism for accelerated development of skeletal muscle dysfunction in COPD. Here, PPARGC1A is linked to chronic obstructive pulmonary disease.